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ABSTRACT OF THE DISCLOSURE
A novel method is provided for determining bacterial
levels in urine samples, which method depends on the
quantitative determination of bacterial adenosine triphos-
phate (ATP) in the presence of non-bacterial ATP. After
the removal of non-bacterial ATP, the bacterial ATP is
released by cell rupture and is measured by an enzymatic
bioluminescent assay using an enzyme obtained from the
firefly.
ORIGIN OF THE INVENTION
The invention described herein was made by employees
of the United States Government and may be manufac-
tured and used by or for the Government for govern-
mental purposes without the payment of any royalties
thereon or therefor.
This is a continuation-in-part of a prior copending ap-
plication, Ser. No. 60,950, filed Aug. 4, 1970, now aban-
doned.
FIELD OF THE INVENTION
This invention relates to a method for detecting and
counting the bacteria present in urine samples and to de-
termine thereby the extent of urinary tract infections.
More particularly, this invention relates to a novel meth-
od for counting bacteria which depends on the presence
and determination of adenosine triphosphate (ATP) which'
is a nucleotide present in all known living matter.
INTRODUCTION
A rapid and routine procedure for the quantitative de-
tection and counting of bacteria is frequently of vital im-
portance. Classical techniques, which have the advantage
of positive identification of the bacteria, are usually slow
and require rather complex media. The technique de-
scribed here for detecting and counting the bacteria pres-
ent in a urine sample offers a high degree of sensitivity,
rapidity, accuracy, and reproducibility. This inventive
process exploits the high specificity and sensitivity of a
bioluminescent enzymatic reaction hi analysing a urine
sample in conjunction with teaching a novel process for
removing interfering compounds from the sample to
render the bioluminescent enzymatic reaction quantitative
for bacterial adenosine triphosphate.
Adenosine triphosphate, hereinafter referred to for con-
venience as ATP, is universally present in all living mat-
ter thereby making this compound an excellent indicator of
the presence of various forms of life, e.g., bacteria. One
of the most sensitive methods for the quantitative assay
of ATP is an enzymatic bioluminescent assay. In this reac-
tion, the bioluminescence occurs as a result of the reac-
tion of ATP with an enzyme luciferase, presently obtained
from fireflies, and a substrate luciferin plus divalent metal
ions such as magnesium or manganese.
It has been previously demonstrated with pure cultures
of a number of bacterial species that the concentration of
bacterial ATP can be closely correlated with bacterial
count. This is discussed in detail by E. W. Chappelle and
G. V. Levin in an article entitled "Use of the Firefly Bio-
luminescent Reaction for Rapid Detection and Counting
of Bacteria" presented in Biochemical Medicine, vol. 2,
pp. 41-52 (June 1968), which article is herein incorpo-
rated by reference. By measuring the ATP content on a
5 unit cell basis of a number of species, an average ATP con-
tent of a bacterial cell has generally been established as
3 X10-10
 Mg. (ranging from 0.28X 10-" /ig. to 8.9x 10-10
To enable use of the ATP assay for the detection of bac-
10 teria in urine, it was necessary to develop a method for the
removal of urinary non-bacterial ATP prior to the detec-
tion of the bacterial ATP. Primary sources of the urinary
non-bacterial ATP are free soluble ATP and ATP in red
and white blood cells. The removal of the non-bacterial
15 ATP is accomplished by first rupturing, by a non-ionic de-
tergent, for example, the red and white blood cells of
the urine sample, thereby releasing the ATP therefrom in
a free soluble state. Next, by the addition of an ATP hy-
drolyzing enzyme (i.e., an ATPase), all the free soluble
20 non-bacterial ATP are hydrolyzed. The ATP hydrolyzing
enzyme is then either denatured (i.e., destroyed) by heat-
ing or inactivated by a chemical means.
After removal of the non-bacterial ATP from the urine
sample, the bacterial ATP is released 'by rupturing the
25 bacteria with acid. Thereafter the acid is neutralized, and
the pH and ionic strength of the urine sample is adjusted
by a buffer for optimal luciferase activity. The urine sam-
ple, at this point of processing, will be referred to as the
treated urine sample. It is combined with a luciferase-
30 luciferin mixture, and, if bacteria are present, the light
emitted from the bioluminescent reaction is detected and
recorded by appropriate apparatus.
The method for determining the ATP present in the
treated urine sample, is based upon a bioluminescent en-
35 zyme system, the same as that occurring in fireflies. The
currently accepted reaction mechanism for this enzyme
system is as follows:
40 E + LH, + ATP
EBH:AMP + Oj
Mg++'i i ELH,AMP + PP
E + AMP + COi + Light + T
E=Firefly luciferase
LH2=Reduced luciferin
ATP=Adenosine triphosphate
45 AMP=Adenosine monophosphate
PP=Pyrophosphate
T=Thiazolinone
Mg++=Magnesium ion
CO2=Carbon dioxide
50 O2= Oxygen
If all of the components of the above reaction are main-
tained in a concentration in excess of the ATP, the emis-
sion of light is directly proportional to the amount of ATP
introduced. This enables one to directly relate the mag-
nitude of light emission to ATP concentration, when the
treated urine sample is combined with the luciferase-luci-
ferin mixture, by using a standard curve prepared as ful-
ly described hereinafter. Further, should one desire to
know the number of bacteria equivalent to the ATP con-
centration in the urine sample, it can be obtained by
simply dividing the ATP concentration, based on the
measure of light emission, by SXlO"10 pg., the average
ATP content of a bacterial cell.
65 DESCRIPTION OF THE PRIOR ART
Methods presently used for determining and counting
bacteria in urine are: (1) culture methods which include
the streak and the pour plate methods; and (2) direct
methods which include microscopic counting and an-
other method which depends upon the ability of orga-
nisms to reduce nitrates to nitrites.
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3 4The streak method is effected by streaking a small quan- sity of requiring the use of experienced personnel as is
tity of urine on a solid agar plate containing nutrients. currently the practice.
The pour plate method is more accurate but far more These and other objects of the present invention will
time consuming since it requites serial dilutions of the become apparent with reference to the following sum-
urine sample to be analyzed followed by mixing precise
 5 mary of the invention and the description of the preferred
aliquots of the dilutions with a preheated liquid bacterial embodiments thereof.
nutrient containing agar. The resultant mixture is then According to the present invention, a method is pro-
poured into a Petri dish and solidifies as a plate upon vided for detecting and counting bacteria in a urine sample
standing. In both of the methods just described, an incu- which method is capable of rupturing the various non-
bation period of from 1 to 4 days is required, after which
 10 bacterial cells containing ATP without affecting the bac-
the plates are examined forbacterial colony growth with terial cells which also contain ATP; hydrolyzing the non-
the number of colonies being a measure of the bacterial bacterial ATP with a suitable hydrolyzing agent followed
count. Both of these methods are semiquantitative at best by treatment of the sample to destroy or inactivate the
and do not permit the detection of non-culturable orga- hydrolyzing agent; rupturing the bacterial cells with acid
nisms which may be of interest. 15 to release the bacterial ATP present therein; neutralizing
Further, a considerable amount of time is required of the acid and adjusting the pH and ionic strength of the
the technician preparing the samples in addition to the sample to a level which will favor the reaction of ATP
necessary time required for incubation of the samples. with a luciferase-luciferin mixture; combining the treated
Although both the streak and pour plate methods of sample with the luciferase-luciferin mixture and measur-
determining bacterial count give results which appear to
 2o
 inS the amount of light emitted therefrom with appropri-
correlate with other symptoms of urinary tract infections, ate equipment, a typical example of such equipment be-
they possess drawbacks. The source of these disadvantages ing thoroughly described in copending continuation-in-
resides in the basic requirement for bacterial growth which part application Ser. No. 139,094, filed concurrently here-
presents certain difficulties; one, for example, is that the with, and entitled Automatic Instrument for Chemical
incubation period, as mentioned, can vary from about 1 25 Processing to Detect Microorganisms in Biological Samples
to about 4 days. A delay of this duration in the diagnosis by Measuring Light Reactions.
of a urinary tract infection could, in some cases, be of In another aspect of the invention, the non-bacterial
critical significance. The validity of the culture methods ATP present as a result of red or white blood cells pres-
can be questioned, considering the fastidious and obligate ent in the sample is removed without affecting the bac-
nature of many bacterial species with regard to specific 30 teria which contain ATP, which ATP will ultimately be
nutrient and environmental requirements. Therefore, when quantitatively determined. After removal of the undesir-
considering that most clinical laboratories use only two able non-bacterial ATP, the bacteria are then ruptured
types of nutrient media in the culture of urine specimens, to release the ATP therefrom, thereby making it avail-
the possibility of failing to detect certain viable organisms able for quantitative determination,
becomes quite real. In fact, experiments have indicated 35 DESCRIPTION OF THE INVENTION
that a significant percentage of urinary bacteria are obli-
gate anerobes. Of course, there are additional reasons for Briefly, a method is provided for detecting and count-
the failure of bacteria to grow such as cell death, dor- ing bacteria in urine which comprises: (a) adding a com-
mancy, and the presence of bacteriostatic agents. pound to a urine sample which is capable of releasing, in
The direct microscopic counting method requires the 40 a free soluble state, the ATP present in non-bacterial mat-
deposition of precise aliquots of the urine sample on a ter contained therein without releasing the ATP con-
calibrated slide. Subsequently, the slide is viewed through tained in the bacteria present in the urine sample; (b) add-
a microscope and the bacteria present are counted. This ing a compound capable of hydrolyzing all free soluble
method suffers from many disadvantages including the non-bacterial ATP; (c) treating the sample to destroy or
time and effort expended by a skilled technician in addi- 45 inactivate the hydrolyzing agent; (d) acidifying the sample
tion to the fact that it cannot be used for the analysis of to rupture the bacteria and release the bacterial ATP con-
turbid samples. The direct microscopic method is gen- tained therein; (e) neutralizing the acid and adjusting the
erally more accurate than the culture techniques since it PH and ionic strength to a level which will favor the bio-
involves the direct counting of the bacteria rather than luminescent reaction of bacterial ATP with a luciferase-
depending upon the ability of the bacteria to grow and 50 lucife™ mixture; (f) combining the above treated urine
form colonies. While this is. a useful technique in some sample with a luciferase-luciferin mixture which contains
situations, it is entirely too tedious and time-consuming a divalent metal cation, such as magnesium or manganese;
for use in a routine clinical laboratory. and (s) detecting and recording the amount of light
emitted from this reaction using photometric equipment
SUMMARY OF THE 'INVENTION
 55 of suitable sensitivity.
To use the ATP assay for the detection of bacteria in
Objects an aqueous physiological system, for example, urine, it
is necessary to develop a means for the removal of non-
Accordingly, it is a primary object of the present in- bacterial ATP from the system. The primary sources of
vention to provide an improved method for detecting and
 go non-bacterial ATP in a urine sample, for example, are
counting bacteria which substantially prevents or allevi- the free soluble ATP and the ATP contained in red and
ates one or more of the disadvantages of the prior art. white blood cells which may also be present with other
Another object is to provide a method for detecting and contaminants in the urine sample. The removal of the
counting bacteria utilizing a bioluminescent reaction of non-bacterial ATP is accomplished by rupturing the red
bacterial ATP when the sample to be analyzed also con-
 gg and white blood cells to release ATP therefrom in a free
tains non-bacterial sources of ATP. soluble state, followed by the addition of an ATP hy-
A further object is to provide a meihod for detecting drolyzing enzyme U-e., ATPase) to destroy the total free
and counting bacteria which yields more accurate results soluble ATP in the urine sample. After either inactiva-
in far less time using much simpler procedures than tion or denaturation (i.e., destruction) of the ATP hy-
methods of the prior art. 70 drolyzing enzyme, the ATP contained in the bacteria is
Another object is to provide a method for detecting and released, by rupture of the bacteria, and reacted with the
counting bacteria in urine samples utilizing the high spec- luciferase-luciferin mixture, resulting in light emission of
ificity of an enzymatic reaction which method is also a magnitude proportional to the ATP concentration and
capable of adaptation to automatic equipment thereby therefore proportional to the bacterial count in the urine
lessening the expenditure of time and obviating the neces- 75 sample.
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Any means may be used to rupture non-bacterial cells
to release ATP therefrom providing the means is suffi-
ciently selective to rupture only non-bacterial cells and is
either not toxic or can be rendered non-toxic. That is,
nothing should interfere with any subseqeunt reaction,
 5
especially the biqluminescent reaction of the bacterial
ATP with the luciferase-luciferin mixture. One way of
rupturing the non-bacterial cells is by a means which re-
duces the surface tension of the non-bacterial cells.
It has been found that certain surfactant compounds, JQ
which lower the surface tension of aqueous solutions,
particularly those classified as cationic, anionic, and non-
ionic detergents, are generally sufficiently selective to
rupture the non-bacterial cells to permit the release of
the ATP therefrom without affecting the bacteria in the 15
sample.
Although cationic and anionic detergents are usable in
the process of this invention, nonionic detergents, such
as octyl phenoxy polyethoxyethanol, are economical,
zyme inhibitors. Physical means include heat and short
wavelength irradiation. It has been found that heating
the urine sample for a brief period, that is, from about 1
to about 15 minutes, preferably for about 5 to 12 minutes,
from 60° C. to 100° C. is effective to denature the hy-
drolyzing enzyme. It has also been noted that the addi-
tion of perchloric acid to the urine sample is effective in
inactivating the hydrolyzing enzyme.
It is easily seen that an entire range of compounds
and procedures may be used to effect the inactivation or
denaturation of the hydrolyzing enzyme, requiring only
that they do, in fact, destroy the activity thereof without
appreciably affecting the bacterial cells or the biolumines-
cent reaction used to determine the bacterial ATP. Any
compound used which is toxic to the luciferase-ATP
reaction would ultimately have to be removed or neu-
tralized.
The denaturation of the hydrolyzing enzyme is gen-
erally carried out at an elevated temperature, preferably
easily obtained, perform most satisfactorily, and are, there-
 2Q 95°'C., and ambient pressure; however, if it should be
fore preferred.
Examples of some other surfactant compounds, falling
within the proper category, are triterpenoid saponins,
steroid, saponins, sulfosuccinates, such as dioctyl sodium
more convenient or necessary to carry this out at elevated
pressures, there is no apparent reason for not doing so.
Although the description so far has been presented
with the nonionic detergent being added to the urine sam-
sulfosuccinates, various glycosides and some polyoxy- 35 P'e pri°r.to tne addition of the ATP hydrolyzing enzyme,
ethylene derivatives of fatty acid partial esters of sorbitol they being added sequentially, it should be understood that
these two ingredients can be added simultaneously, either
separately or as a mixture.
Once the potentially interfering non-bacterial ATP has
30 been effectively removed from the urine sample and the
hydrolyzing enzyme has been inactivated or denatured,
the sample is cooled to ambient temperature. Then the
bacterial ATP is liberated by rupturing the cell walls of
anhydrides.
The rupturing of the non-bacterial cells is generally
conducted at ambient temperature and ambient pressure
with the urine sample being allowed to stand for from
about 1 minute to about an hour, preferably from 5 to 20
minutes, and most preferably approximately 10 minutes.
The amount of time the urine sample is allowed to stand,
for example, when a nonionic detergent such as octyl the bacteria present, and the ATP so released is reacted
phenoxy polyethoxyethanol, has been added to the urine 35 with the luciferase-luciferin combination as indicated
sample, is partially dependent upon the temperature since
the rate of rupture will be increased appreciably for
each degree increase hi temperature. On long standing
or at elevated temperatures, however, the nonionic de-
previously.
• Many different compounds and procedures may be used
to rupture the cell walls of the bacteria and liberate the
bacterial ATP. These include organic acids, such as acetic
tergent might begin to atack the bacteria, thereby re- 40 and formic acid, and inorganic acids, such as perchloric
acid, hydrochloric acid, sulfuric acid, phosphoric acid, and
nitric acid. In addition, ultrasonic vibrations and some
organic solvents, such as butanol, are effective in releas-
ing the bacterial ATP. Again, the basic requirements for
during the precision and accuracy of the method.
The nonionic detergent, octyl phenoxy polyethoxyeth-
anol, when used as the rupturing agent, performs best
when it is at a concentration of from about 0.05 to about
5.0 percent by volume and is added to the urine sample 45- this reagent are that it rupture the bacterial walls to
in an amount equivalent to approximately 5 to 15% of liberate the ATP without reacting with the ATP and
without interfering with the subsequent reactions, espe-
cially the bioluminescent reaction of the ATP with the
luciferase-luciferin combination.
50-
the volume of the urine sample.
After the non-bacterial cells containing ATP have been
selectively ruptured by the octyl phenoxy polyethoxy-
ethanol and the ATP has been released from the non-
bacterial cells in a free soluble state, a compound is added
to the urine sample which is capable of hydrolyzing the
total free soluble ATP in the urine sample. The most spe-
cific non-toxic means of hydrolyzing ATP is by the use
of ATP hydrolyzing enzymes commonly referred to as 55-
ATPases. Any ATPase may be used, for example, potato
apyrase, insect apyrase, muscle ATPase, and liver
ATPase. Potato apyrase, since it is more completely char-
acterized, easily purified, easily obtained, and yields ex-
cellent results, is the preferred hydrolyzing agent for etf
use in the practice of this invention.
After adding the ATPase, the urine sample is allowed
to stand at ambient temperature and pressure for a time
sufficient to allow the hydrolysis to proceed to completion.
It has been found that perchloric acid is exceptionally
suitable for this step; and, after the addition of a small
amount of perchloric acid at a relatively low concentra-
tion, the sample is allowed to stand for from about 10
seconds to about 15 minutes, preferably from about 1 to
about 7 minutes. The reaction is rapid and does not re-
quire a great amount of time to liberate the bacterial
ATP. If the sample is allowed to stand for too long a
time after the perchloric acid is added, the ATP which
is released from the bacteria may be adversely affected
by the acid. If too much acid is used, precision of the
ultimate analysis will be affected since the acid anion has
an adverse effect on the bioluminescent reaction.
. Although the speed of the reaction will be increased
for each incremental increase in temperature, it has been
Generally, the sample is allowed to stand from about 1 65 found ^at rupturing of the bacteria is generally optimum
to about 25 minutes, and preferably about 5 to about 15 a* ambient temperature, there being no appreciable bene-
fit at elevated temperatures which can very well work tominutes.
Once the non-bacterial ATP has been liberated and
hydrolyzed with the ATPase, the hydrolyzing enzyme
must be inactivated or destroyed (denaturation of the
enzyme) to prevent interference with the analysis of the
ATP subsequently released from the bacteria. This can
be done by physical means or by chemical agents. Typical
chemical agents are acid, bases, salts of heavy metals,
a detriment hi that the ATP could be destroyed. Further,
while it is most convenient to rupture the bacteria at
70 ambient temperatures, there is no reason why this cannot
be done at temperatures down to 5° C.
• In a 1.0 ml. sample of urine, wherein perchloric acid
is used to release the bacterial ATP, an amount in the
range of 0.05 ml. to 1.0 ml. of a 0.05 to 5.0 N perchloric
organic solvents, and those compounds classified as en- 75 acid solution can be used. An insufficient amount of acid
3,745,090
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pensing means. Also associated with the rotatable table
are heating means, cooling means, and photodetecting
means, all precisely located, as are the dispensing means,
so that the proper timing sequence, as outlined above, for
each operation of the process is performed. It is to be
pointed out that the area in which the bioluminescence
reaction takes place and whereat the photodetecting
means is located, to provide a measure of the light being
given off, is light tight so that the photodetecting means
will not rupture the cell walls of the bacteria while an
excess of the acid may have an adverse effect on the ATP
after it is released.
Neutralization of the acid can be effected with an or-
ganic or an inorganic base. Examples of such bases in-
elude alkali metal hydroxides and alkaline earth metal
hydroxides, along with those organic compounds capable
of accepting hydrogen ions without adversely affecting the
bioluminescent reaction of interest here. The fundamental
requirement of the base is, of course, that it be able to 10 will only register the light from the bioluminescence re-
neutralize the acid. In addition, a preferred base will action. Further, should it be desired to inactivate the hy-
be one wherein the cation of the base will react with an drolyzing agent by chemical means, the heating means
interfering anion of an acid of the previous step, to form
an insoluble precipitate, thereby removing harmful ions
from the sample and avoiding future interferences with 15
the analysis by these ions. This is preferred as is any other
arrangement which will remove ions which may inter-
fere with the bioluminescent reaction. This, of course, is
practical from an economic standpoint also, since an ad-
ditional step in the analysis is obviated, namely, the re- 20 !°_pr,a(:ti(ie,*e invention and to represent one mode con-
quirement that these ions be removed prior to the bio- * • - ' - - • * — - ~ « * i - - - -
luminescent reaction.
The amount of base used may range from 0.05 ml. to
1.0 ml. of a 0.05 to 5.0 N potassium hydroxide solution.
An insufficient amount of base will not effectively neu- 25
tralize the acid, and an excess of the base may be harm-
ful to the ATP released from the bacteria.
The ultimate pH and ionic strength of the sample is
then adjusted with a buffer which can be added thereto
and a portion of the cooling means can be made to be
inoperative.
The invention is further illustrated by the following ex-
amples in which all parts and percentages are by weight
unless otherwise indicated. These examples are illustrative
of results obtained with one embodiment of the invention
and are provided to teach those skilled in the art how
templated for carrying out the invention.
EXAMPLES I—XVII
Introduction
The procedure used, in the analysis of the samples
given in Table I below, involved obtaining a urine sam-
ple and treating it to remove both the ATP in free soluble
state and also that in any red or white blood cells present
in the sample. This was accomplished by selectively rup-
either substantially at the same time the base is added 30 luring the red and white blood cells with Triton X-100
or any time thereafter. The buffer serves to maintain the
pH of the urine sample fairly precisely at about 7.4, which
is the optimal pH for maximum activity of the luciferase-
luciferin combination. If the hydrogen ion activity (pH)
should become, appreciably lower or appreciably higher, 35 imately 95° C. to denature the potato apyrase. Thereafter,
the ultimate precision of the analysis will suffer due to the sample was acidfied with perchloric acid to rupture
the decreased activity of the luciferase-luciferin combina-
tion. Furthermore, in the presence of a buffer, the vol-
umes of acid and base required in the previous steps need . . . ,_, ,
not be quite so critical since the buffer will compensate 40 VO- methyl-2-aminoethanesulfonic acid]. A portion of
for any minor discrepancies. Any buffer may be used tois treated urine sample was then combined, as more
which maintains the pH of the urine sample in the range
of about 6.8 to 7.8 preferably 7.2 to 7.6, and most prefer-
ably, approximately 7.4, without interfering with the prin-
cipal reaction. The quantity of the buffer which is added 45
generally falls within the range of about 0.05 ml. to about
1.0 ml. at a concentration of about 2 to 2.5 M. Buffers
which fulfill these requirements and can be used in the
process of the instant invention include TES buffer [N-
tris (hydroxymethyl) methyl - 2 - aminoethanesulfonic 60 to ;
acid]; phosphate buffers; arsenate buffers; tris buffers,
e.g. tris (hydroxymethyl) aminomethane; arsine buffers;
glycyglycine buffer; and N-2-hydroxyethyIpiperazine-N-2-
ethanesulfonic acid buffer. .. , - . ....
The treated urine sample, as prepared above, is then 55 add<?d.thereto- and the sample was allowed to stand for
combined with the luciferase-luciferin combination con- minutes,
taining divalent magnesium or manganese ions, and the
light given off during the bioluminescent reaction is meas-
ured with appropriate instrumentation. ,,. __
A complete and detailed description of an instrument 60 ,,,W . L?. p? of "je samPle was brought to 7.4
which can automate the above described process, includ- Oaoogk addition of 0.1 ml. of 2.0 M TES buffer [N-tris
ing measuring the light emitted in the bioluminescent re-
action, can be found in copending continuation-in-part ap-
plication, Ser. No. 139,094, filed concurrently herewith,
and entitled Automatic Instrument for Chemical Proc- 65
essing to Detect Microorganisms in Biological Samples
by Measuring Light Reactions, the disclosure of which is
herein incorporated by reference.
This instrument generally includes a rotatable table _ . _ _ _ ,
 r..f
having spaced receptacles therein for continually receiv- 70 the lanterns, was mixed with 10 ml. of cold OX)5 M TES
ing vials of urine samples automatically fed thereto and buffer and stirred 30 minutes. After centrifuging the
for thereafter moving the vials past a plurality of dis- mixture at 13,000xg for 15 minutes, the supernatant
pensing means which sequentially dispense a predeter- solution was placed on a Sephadex G-200 (registered
mined quantity of the various ingredients, used in the trademark for dextran beads which separate compounds
process, into the vials as the vials pass the respective dis- 75 on the basis of molecular weight) column equilibrated
(registered trademark of the Rohm and Haas Corpora-
tion for a brand of octyl phenoxy polyethoxyethanol) and
adding potato apyrase, an ATP hydrolyzing enzyme. After
a short time, the urine sample was heated to approx-
the bacteria and then neutralized with potassium hydrox-
ide solution prior to adjusting the pH of the sample to
approximately 7.4 with TES buffer [N-tris (hydroxymeth-
fully explained below, with the luciferase-luciferin com-
bination containing divalent magnesium or manganese
ions, and the light given off measured.
Treatment of urine samples
(a) A 1.0 ml. sample of urine was mixed with 0.1 ml.
of. a 1% by volume Triton X-100 solution and a 0.1 ml.
of a potato apyrase solution (described infra) and allowed
: ambient temperature for 10 minutes,
sample was then heated at approximately 95°
C. for 10 minutes to denature the potato apyrase. After
heating, the sample was allowed to cool to ambient tem-
and then 0.1 ml. of 1.0 N perchloric acid was
(c) The perchloric acid solution was then neutralized
through the addition of 0.1 ml. of a 1.0 N potassium hy-
droxide solution.
pH of the sample was brought
 .  l.  .    ff r t i
(hydroxymethyl) methyl-2 - aminoethanesulfonic acid],
thereby obtaining the treated urine sample.
Preparation of the luciferase-luciferin mixture
Partially purified firefly luciferase was prepared from
dried firefly lanterns obtained from the Antonik Labo-
ratories, Elk Grove, HI., for example, in the following
manner. One gram of an acetone powder, prepared from
3,745,090
with 0.05 M TES buffer at a pH of 7.4 and eluted with
the same buffer. The fractions obtained from the column
were assayed for luciferase activity by removing 0.2 ml.
aliquots to which 0.1 ml. of the TES buffer, containing
synthetic luciferin (0.1 mg./ml.) and magnesium sulfate g
(0.01 M) was added. Luciferase activity was measured
on the basis of the light emission upon the addition of
10~2 /ig. of ATP to the mixture. The most active frac-
tions obtained from the column, based upon magnitude
of light emission, were selected, pooled, and mixed with JQ
a luciferin-magnesium solution [1 part luciferase to 2
parts luciferin (0.1 mg./ml.)-magnesium sulfate (0.01
m)] and then lyophilized in 10 ml. volumes. The lyo-
philized mixtures were then stored at —40° C. and pre-
pared for use as needed by the addition of 10 ml. of jg'
distilled water.
Preparation of potato apyrase
The potato apyrase was prepared by peeling and dic-
ing 500 grams of white potatoes, adding them to 250 go
ml. of cool distilled water and homogenizing in a blender
for 5 minutes. The suspension was then filtered through
2 layers of cheese cloth and the filtrate taken to 20%
saturation with ammonium sulfate after which the pH
was adjusted to approximately 4.0. Additional ammoni- ^5
urn sulfate was then added to achieve 40% saturation,
and the mixture was centrifuged at 13,OOOXg for 15
minutes at room temperature. The precipitate was dis-
carded, and the supernatant solution was brought to 75%
saturation with ammonium sulfate. After standing 15
 30
minutes at room temperature, the mixture was centri-
fuged as above. The precipitate was then dissolved in
50 ml. of distilled water. The extract was placed on a
Sephadex G-100 column equilibrated with 0.01 M cal-
cium chloride in 0.05 M TES buffer at a pH of 7.4.
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The resultant fractions were assayed for apyrase activity
by adding 0.1 ml. aliquots of each fraction of 1 /ig. of
ATP, contained in 1 ml. of solution, and allowing the
aliquots to stand for 5 minutes, after which the remain-
ing ATP was measured by using the firefly luciferase 40
assay. Active fractions were those showing a complete
disappearance of ATP. These fractions were pooled, ly-
ophilized, and stored at —40° C. At such time as they
are to be used, they are reconstituted by the addition
of distilled water. 45
Preparation of synthetic luciferin
The luciferin was prepared according to the method of
White et al., as presented in the Journal of the American
Chemical Society, vol. 85, pp. 337-343 (1963), which 50
is herein incorporated by reference.
Procedure
By means of a needle and syringe, 0.1 ml. of the
treated urine sample, prepared in the manner described 55
above, was injected into a cuvette containing 0.3 ml.
of the luciferase-luciferin combination containing mag-
nesium. This was done for each of the 17 samples. In
carrying out this procedure, each cuvette arid a photo-
detecting means were positioned with respect to each go
other in a light tight chamber so that the light given
off by the bioluminescence reaction, within the respective
cuvette, could be detected by the photodetecting means
and thereafter measured by a recording means, electrical-
ly coupled to the photodetecting means. . 65
A standard curve relating the magnitude of light emis-
sion to ATP concentration was plotted as follows:
A number of 0.1 ml. samples containing known quan-
tities of pure ATP in solution form and covering the
range of from 10-1 /ig. to 10~5 /ig. were prepared. Each 70
of the samples of ATP was individually injected into
a separate cuvette of freshly hydrated luciferase-luciferin
mixture (made in the manner described above), and the
magnitude of the light emitted from each of the re-
spective resultant luminescent reactions was measured. 75
10
Both .the. injection of the ATP and the measurement of
the emitted light were performed in the fashion identical
to that just described with respect to the urine sample.
For each of the 0.1 ml. samples of a known quantity of
ATP, a particular light emission value was obtained.
These light emission values were plotted versus the cor-
responding quantity of ATP to form the standard curve.
Using this standard curve, the light emission values,
obtained from the 17 urine samples and measured by
the recording means, were converted into ATP concen-
trations. It should be understood, due to daily variations
in the luciferase activity, that a standard curve should
be prepared each day to obtain the most accurate re-
sults.
The bacterial counts as listed in the second column of
Table I below were individually calculated by dividing
the ATP concentrations of each of the 17 urine samples,
as obtained from the standard curve, by SxlO"10 /ig.,
which is the mean ATP content of a bacterial cell.
The bacterial counts obtained by the ATP method were
compared with the bacterial counts obtained on the same
sample using the pour plate and microscopic techniques.
The third and fourth columns of Table I below list this
latter data. The procedures for the pour plate and micro-
scopic bacterial counting are generally well known and
therefore not described herein.
TABLE I
Determination of the number of bacteria/ml, by various methods
ATP
method Pour plate Microscopic
Sample:
. i
2
3
4
5
6
7
8
9
10 . .
11
12
13
14
15
- 16
17
. ..._• 8X10'
8X10'
7X10>
.... 9X10»
4X10'
.... 7X10'
4X10'
3X10'
5X10>
3X10'
8X10'
6X10'
2X101
4X10' ...
. . . 5X10»
3X10'
1X10'
4X103
9X10"
2X10»
2X10'
3X10»
1X10<
1X10'
2X10'
3X105
(*)
C)
2X10'
8X101
3X10'
C)
2X103
6X10'.
7X10'
2X10»
2X10»
8X10'
2X10'
. 2X10«
4X10"
1X10»
2X10'
2X10'
3X10»
2X10'
4X10'
7X10>
2X10'.
1X10»
•Indicates that no organisms grew.
Table I above illustrates results obtained with the meth-
od of the instant invention as used to determine bacterial
concentration in urine samples as compared with two
other methods currently in use. Of the other two methods,
namely the pour plate method and microscopic method,
the microscopic method is generally more accurate. A
comparison'of the values obtained using the ATP method
as against the pour plate method indicate that the ATP
method is far more accurate than the pour plate method,
which also suffers by being more time consuming and ex-
tremely laborious. It can be seen from an inspection of
Table I that the ATP method more closely correlates
with the microscopic method whereas the pour plate
method varies by as much as 6 orders of magnitude.
While not presented in tabular form, urine specimens
from 700 patients at the Johns Hopkins Hospital were
assayed for bacteria and the results compared with those
obtained by the pour plate technique. In all cases where
the colony count exceeded 10,000 per ml. by the pour
plate culture, the ATP response was positive. Moreover,
in most instances, the bacterial count obtained by the ATP
assay was much higher than that obtained by the colony
count. In fact, in a significant number of cases, where the
ATP assay was positive, the colony count was negative.
The possible explanations for these discrepancies have
been described earlier.
ALTERNATIVE EMBODIMENT
Although the process thus far described includes the
steps of heat denaturing the ATP hydrolyzing enzyme
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when compared with methods of the prior art since no
incubation period is required during which the bacteria
grow on the nutrient substrate. Furthermore, this analysis
can be conducted by non-microbiologists, and the more
g highly skilled personnel can be utilized more effectively.
The test is suitable for all bacteria, living or dead;
it is not limited to those capable of aerobic growth; it
is independent of the type of nutrient required by the
bacteria for proper growth; and it is generally unaffected
and pour plate methods used hi analysing the same sam-
ples. It can be observed that comments given above for
Table I apply equally as well to Table II.
TABLE II
Determination of the number of bacteria/ml, by various methods
ATPase (potato apyrase solution), followed by cooling
the urine sample to ambient temperature, it should be
pointed out that these steps, as well as the step of neu-
tralizing the perchloric acid through the addition of the
base (potassium hydroxide solution), can be omitted if
not more than ten seconds elapses between the addition
of the buffer and the addition of the luciferase-luciferin
mixture. This requirement can readily be fulfilled by an
automated instrument. In this situation, the acid (per-
chloric acid) is added to the urine sample after there has
 10 by the presence of bacteriostatic agents which inhibit
been approximately 10 minutes incubation period of the growth.
Triton X-100 and potato apyrase solution that are already The method is not only suitable for use in analyzing
contained in the urine sample. The perchloric acid, in urine samples to determine urinary tract infections by
this instance, both inactivates the hydrolyzing enzyme and measuring the level of bacteria, but it is also adaptable
ruptures any bacteria present. Again, as in the earlier
 lg to the determination of bacterial levels in other aqueous
described process, the urine sample, with the perchloric body fluids such as lymph fluid, plasma, blood, spinal
acid added, is allowed to stand for five minutes and the fluid, saliva, and mucus, to name only a few. Further, it
urine sample brought to a final pH of 7.4 through the is particularly applicable to measuring bacterial levels in
addition of a buffer, in this case a tris buffer, preferably aqueous body fluids which have, in addition to the bac-
2.5 M tris (hydroxymethyl) aminomethane, thereby ob-
 20 teria, both free soluble ATP and non-bacterial cells con-
taining the treated urine sample which is then immedi- taining ATP.
ately mixed with the luciferase-luciferin combination con- The principles, preferred embodiments, and modes of
taining magnesium. operation of the present invention have been described
A number of urine samples were tested using this alter- in the foregoing specification. The invention which is
native process. The results obtained are given in Table II
 25 intended to be protected herein, however, is not to be
along with those obtained by conventional microscopic construed as limited to the particular forms disclosed
since these are to be regarded as illustrative rather than
restrictive. Variations and changes may be made by
those skilled in the art without departing from the spirit
30 of the present invention.
For example, when the invention is performed in the
automated instrument, referred to above, rather than
starting with 1.0 ml. of urine sample, which after being
treated, has 0.1 ml. of the treated sample injected into
Pour plate Microscopic
 3g a cuvette containing the luciferase-luciferin mixture; the
plurality of vials fed to the rotatable table each contain
0.1 ml. of urine sample and each of the ingredients are
added thereto sequentially in a particular timing sequence
has the luciferase-luciferin mixture injected therein. This
2x10* 40 is in contrast to the general method described in which
the sample is injected into the cuvette containing the
luciferase-luciferin mixture.
What is claimed is:
1. A method of detecting and counting bacteria in a
45 urine sample which contains bacterial and non-bacterial
cells containing adenosine triphosphate comprising:
(a) treating said urine sample by rupturing the non-
bacterial cells to release adenosine triphosphate pres-
ent in the non-bacterial cells without rupturing the
bacterial cells;
(b) enzymatically hydrolyzing the non-bacterial adeno-
sine triphosphate;
(c) removing the hydrolyzing agent;
(d) rupturing the bacterial cells, thereby releasing
adenosine triphosphate;
(e) adjusting the hydrogen ion concentration of the
sample to a level favorable to a bioluminescent re-
action of adenosine triphosphate and a luciferase-
luciferin mixture to form a treated urine sample;
(f) combining the treated urine sample with a luci-
ferase-luciferin mixture which mixture also contain a
divalent metal cation selected from the group consist-
ing essentially of magnesium and manganese; and
(g) recording the amount of light emitted therefrom.
2. The method of claim 1 wherein:
(a) rupturing the non-bacterial cells containing adeno-
sine triphosphate is accomplished by a compound
which reduces surface tension sufficiently to release
the non-bacterial adenosine triphosphate;
(b) hydrolyzing said non-bacterial adenosine triphos-
phate is done with an adenosine triphosphate hy-
drolyzing enzyme;
(c) removing the hydrolyzing enzyme is carried out by
heat denaturation;
(d) rupturing the bacterial cells is performed by acidi-
Sample:
2
3 . ,
4
5
6
7
8
9
Alternative
ATP
method 1
. ... 2.8X10'
7.4X10'
2 3X10»
6.6X10'
0
6X10'
6.6X10'
- - . 0
2X10'
Pour plate 1
1X10'
2X10»
1X10>
IXIOJ
(*)
1X10>
4X10'
(*)
1X10?
icroscopic
2.4X101
1X10»
1X10»
2.3X10'
0
X
6X10'
0
2X10<
•Indicates that no organisms grew.
Processing urine samples utilizing the alternative
embodiments
(a) A 1.0 ml. sample of urine was mixed with 0.1 ml.
of a 1% by volume Triton X-100 solution and 0.1 ml.
of a potato apyrase solution and allowed to stand at am- 50
bient temperature for 10 minutes.
(b) Next 0.1 ml. of 1.0 N perchloric acid was added
and the sample allowed to stand for five minutes. In this
instance the perchloric acid both inactivated the potato
apyrase (hydrolyzing enzyme) and ruptured the bacteria 55
present to release the ATP therefrom.
(c) Then the final pH of the sample was brought to
7.4 through addition of 0.1 ml. of 2.5 M tris (hydroxy-
methyl) aminomethane (a tris buffer), thereby obtaining
the treated urine sample.
(d) Immediately 0.1 ml. of the treated urine sample
was injected into a cuvette containing 0.3 ml. of the
luciferase-luciferin combination containing magnesium,
the cuvette being positioned adjacent to a photodetecting
means in a light tight chamber so that the light given off 65
by the bioluminescent reaction could be detected by the
photodetecting means and thereafter measured by a re-
cording means electrically coupled to the photodetecting
means.
The above steps a-d were repeated for each urine 70
sample.
GENERAL COMMENTS
The method of the instant invention, as disclosed here-
in, results in a saving of a considerable amount of time 75
60
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fying the sample; and which further includes the step
of:
(e) neutralizing the acidified sample with a suitable
. base prior to adjusting the hydrogen ion concentra-
tion of the sample to the level which will favor the
 g
bioluminescent reaction of the adenosine triphos-
phate with the luciferase-luciferin mixture.
3. The method of claim 2 wherein the sample is heated
to a temperature in excess of 60° C. for time sufficient to
insure the denaturation of the hydrolyzing enzyme; and
 LQ
.the hydrogen ion concentration of the neutralized sample
is adjusted with a buffer solution to form the treated
urine sample with a pH of about 6.8 to about 7.8.
4. The method of claim 2 wherein:
(a) acidifying is achieved with an acid selected from 15
the group consisting essentially of perchloric acid,
hydrochloric acid, sulfuric acid, acetic acid, phos-
phoric acid, and nitric acid;
(b) neutralizing is accomplished with a base selected
from the group consisting essentially of alkali metal 20
hydroxides and alkaline earth metal hydroxides; and
(c) adjusting the hydrogen ion concentration is car-
ried out with a buffer which maintains a pH of from
about 6,8 about 7.8.
5. A method of detecting and counting bacteria in a 25
urine sample which contains bacterial and non-bacterial
cells containing adenosine triphosphate comprising:
(a) treating said urine sample by rupturing the non-
bacterial cells to release adenosine triphosphate pres-
ent therein without rupturing the bacterial cells; 30
(b) hydrolyzing the non-bacterial adenosine triphos-
phate with a hydrolyzing enzyme and allowing the
mixture to stand for a tune sufficient to effect the
hydrolysis;
(c) acidifying the sample to rupture the bacterial cells; 35
(d) neutralizing said sample with an appropriate base;
(e) adjusting the hydrogen ion concentration with a
buffer to form a treated urine sample which main-
tains a pH of from about 6.8 to about 7.8;
(f) combining the treated urine sample with a luci- 40
ferase-luciferin mixture containing a divalent metal
cation selected from the group consisting essentially
of magnesium and manganese; and
(g) recording the amount of light emitted therefrom.
6. The method of claim 5 wherein: 45
(a) the non-bacterial cells containing adenosine triphos-
phate are ruptured by a non-ionic detergent;
(b) the adenosine triphosphate hydrolyzing enzyme is
an ATPase;
(c) the sample is heated from 60° C. to 100° C. for 50
from about 1 to about 15 minutes to denature the
apyrase;
- (d) the sample is acidified with an inorganic acid to
rupture the bacterial cells;
(e) the sample is neutralized with an alkali metal base; 55
and
. (f) the hydrogen ion concentration is adjusted using
a buffer maintaining a pH from about 7.0 to about
7.6.
7. The method of claim 6 wherein the non-ionic deter- 60
gent is octyl phenoxy polyethoxyetbanol, the ATPase is
potato apyrase solution, the inorganic acid is perchloric
acid, and the alkali metal base is potassium hydroxide.
«. The method of claim 7 wherein:
(a) the octyl phenoxy polyethoxyethanol is at a con- go
centration of about 0.05 to about 5.0 percent by
volume and is added to the sample in an amount
equivalent to approximately 5 to 15 percent of the
volume of said sample;
(b) an amount of the potato apyrase solution is added 70
to provide an excess over that required for the hy-
drolysis of the non-bacterial adenosine triphosphate
and the sample is allowed to stand for a time suf-
ficient to effect the rupturing and hydrolysis;
(c) the sample is heated at 95° C. from about 5 to 75
about 15 minutes to insure denaturation of the potato
apyrase;
(d) the sample is acidified with the perchloric acid in
a concentration of from 0.05 to 5.0 N and allowed
to stand for from about 10 seconds to about 15 min-
utes to insure the bacterial rupture;
(e) said perchloric acid is neutralized with potassium
hydroxide in a concentration of from 0.05 to 5.0
N such that potassium ions form an insoluble precipi-
tate with the perchlorate ions; and
(f) the hydrogen ion concentration is adjusted with a
non-interfering buffer which maintains a pH of from
about 7.2 to about 7.6.
9. The method of claim 8 wherein:
(a) 0.1 ml. of a 1 percent solution by volume of octyl
phenoxy polyethoxyethanol is added to 1.0 ml. of
the urine sample and 0.1 ml. of a potato apyrase so-
lution is combined therewith, the sample being al-
lowed to stand at ambient temperature for from
about 3 to about 20 minutes;
(b) the perchloric acid solution is neutralized with po-
tassium hydroxide and the hydrogen ion concentra-
tion is adjusted using N-tris (hydroxymethyl) meth-
yl-2-aminoethanesulfonic acid; and
(c) 0.1 ml. of the treated urine sample is then added
to a luciferase-luciferin mixture containing mag-
nesium.
10. The method of claim 8 wherein:'
(a) 0.1 ml. of a 1 percent solution by volume of octyl
phenoxy polyethoxyethanol is added to 1.0 ml. of
the urine sample and 0.1 ml. of a potato apyrase
solution is combined therewith, the sample being al-
lowed to stand at ambient temperature for from
about 5 to about 20 minutes;
(b) the sample is heated at 95° C. for from about 8
to 12 minutes to insure denaturation of the potato
apyrase;
(c) the sample is acidified with about 0.1 ml. of 1.0
N perchloric acid and allowed to stand at ambient
temperature for approximately 5 minutes;
(d) the perchloric acid solution is neutralized by add-
ing 0.1 ml. of a 1.0 N solution of potassium hy-
droxide;
(e) the hydrogen ion concentration is adjusted to
maintain the pH at about 7.4 by adding 0.1 ml. of
2 M N-tris (hydroxymethyl) methyl-2-aminoethane-
sulfonic acid; and
(f) 0.1 ml. of the treated urine sample is then added
to 0.3 ml. of a luciferase-luciferin mixture contain-
ing magnesium.
11. A method of detecting and counting bacteria in a
urine sample which contains bacterial and non-bacterial
cells containing adenosine triphosphate comprising:
(a) treating said urine sample to remove the non-bac-
terial adenosine triphosphate present in said sam-
ple by enzymatic hydrolysis without affecting the
bacterial cells;
(b) releasing the bacterial adenosine triphosphate pres-
ent in the sample;
(c) adjusting the hydrogen ion concentration of the
sample to a level favorable to a bioluminescent re-
action of adenosine triphosphate with a luciferase-
luciferin mixture, thereby forming a treated urine
sample;
(d) combining the treated urine sample with the lu-
ciferase-luciferin mixture, which mixture also con-
tains a divalent metal cation selected from the group
consisting essentially of magnesium and manganese;
and
(e) detecting the amount of light emitted therefrom.
12. A method of removing non-bacterial adenosine tri-
phosphate present in an aqueous body fluid containing
both non-bacterial and bacterial cells, said method com-
prising the steps of:
(a) treating said aqueous body fluid by rupturing the
15
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non-bacterial cells to release adenosine triphosphate
present in the aqueous body fluid without affecting
the bacterial cells;
(b) enzymatically hydrolyzing the non-bacterial aden-
osine triphosphate; and
(c) inactivating the hydrolyzing agent.
13. The method of claim 12 wherein:
(a) the non-bacterial cells containing adenosine tri-
phosphate are ruptured by a non-ionic detergent;
(b) the hydrolyzing is performed by an ATPase; and
(c) the inactivation is carried out from about 1 to
about 15 minutes at a temperature from about 60°
C. to about 100° C.
14. The method of claim 12 wherein:
(a) the non-bacterial cells containing adenosine tri-
phosphate are ruptured by a non-ionic detergent;
(b) the hydrolyzing is performed by an ATPase; and
(c) the inactivating is performed by an acid.
15. A method of detecting and counting bacteria in a
urine sample which contains bacterial and non-bacterial
 2o
adenosine triphosphate comprising the steps of:
(a) treating said urine sample to effect the removal of
non-bacterial adenosine triphosphate present in said
sample in both non-bacterial cells and in its free solu-
ble state by enzymatic hydrolysis without affecting
 2s
the bacterial cells;
(b) treating the urine sample to effect the release of
the adenosine triphosphate from the bacterial cells
present in the urine sample;
(c) adjusting the hydrogen ion concentration of the
sample to a level favorable to a bioluminescent re-
action of adenosine triphosphate and luciferase-lu-
ciferin mixture to form a treated urine sample;
(d) combining the treated urine sample with a lucif-
erase-luciferin mixture, which mixture also contains
a divalent metal cation selected from the group con-
sisting essentially of magnesium and manganese;
(e) recording the amount of light emitted therefrom.
16. The method of claim IS wherein the removal of
the non-bacterial adenosine triphosphate present in the
sample in both non-bacterial cells and in its free solu-
ble state is accomplished by:
(a) rupturing the non-bacterial cells to release the
adenosine triphosphate present therein, and
(b) hydrolyzing the non-bacterial adenosine triphos-
phate with a hydrolyzing enzyme and allowing the
mixture to stand for a time sufficient to effect hy-
drolysis; and
the release of the adenosine triphosphate from the bac-
teria] cells in the sample is accomplished by:
acidifying the sample to inactivate the hydrolyzing
enzyme and rupture the bacterial cells.
17. The method of claim 16 wherein rupturing the non-
bacterial cells is performed by a non-ionic detergent,
hydrolyzing the non-bacterial adenosine triphosphate is
performed by an ATPase, acidifying the sample is per-
formed by an inorganic acid, and the hydrogen ion con-
centration is adjusted to a pH from about 7.0 to about
7.6 by a buffer agent.
18. The method of claim 17 . wherein the non-ionic
detergent is octyl phenoxy polyethoxyethanol, the ATPase
is potato apyrase solution, the inorganic acid is perchloric
acid, and the buffer agent is a tris buffer.
19. The method of claim 18 wherein:
(a) the octyl phenoxy polyethoxyethanol is at a con-
39
35
40
45
50
55
60
65
16
centration of about 0.05 to about 5.0 percent by
volume and is added to the sample in an amount
equivalent to approximately 5 to 15 percent by
volume of said sample;
(b) the amount of the potato apyrase solution is added
to provide an excess over that required for the hy-
drolysis of the non-bacterial adenosine triphosphate
and the sample is allowed to stand for about 3 to
20 minutes;
(c) the sample is acidified with the perchloric acid in
a concentration of from 0.05 to 5.0 N and allowed
to stand for 3 to 10 minutes to insure inactivation of
the hydrolyzing enzyme and rupturing of the bac-
terial cells;
(d) and the hydrogen ion concentration is adjusted
with tris buffer 2.5 M tris (hydroxymethyl) amino-
methane to maintain the pH of from 7.2 to 7.6.
20. The method of claim 19 wherein:
(a) 0.1 ml. of a 1 percent solution by volume of octyl
phenoxy polyethoxyethanol is added to 1.0 ml. of
the urine sample and 0.1 ml. of potato apyrase solu-
tion is combined therewith, the sample being allowed
to stand for about 5 to about 20 minutes;
(b) the potato apyrase solution is inactivated and the
sample is acidified with about 0.1 ml. of 1.0 N per-
chloric acid, the sample being allowed to stand for
approximately 10 minutes;
(c) the hydrogen ion concentration is adjusted to main-
tain the pH at about 7.4 by adding 0.1 ml. of 2.5 M
tris (hydroxymethyl) aminomethane; and
(d) 0.1 ml. of the treated urine sample is immediately
added to 0.3 ml. of a luciferase-luciferin mixture
containing magnesium.
21. A method of detecting and counting bacteria in an
aqueous body fluid which contains both non-bacterial and
bacterial cells containing adenosine triphosphate and also
including adenosine triphosphate in its free soluble state
comprising the steps of:
(a) treating said aqueous body fluid to effect removal
of non-bacterial adenosine triphosphate present in
said aqueous body fluid in both non-bacterial cells
and in its free soluble state by enzymatic hydrolysis
without affecting the bacterial cells;
(b) treating the aqueous body fluid to effect the re-
lease of the adenosine triphosphate from the bacterial
cells present therein;
(c) adjusting the hydrogen ion concentration of the
aqueous body fluid to a level favorable to a bio-
luminescent reaction of adenosine triphosphate and
luciferase-luciferin mixture to form a treated aque-
ous body fluid;
(d) combining the treated aqueous body fluid with a
luciferase-luciferin mixture, which mixture also in-
cludes a divalent metal cation selected from the group
consisting essentially of magnesium and manganese;
and
(e) recording the amount of light emitted therefrom.
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